Late i.v. steroid treatment for severe COVID‐19‐induced acute respiratory distress syndrome: a case report

Kumakawa, Yasuaki; Hirano, Yohei; Sueyoshi, Koichiro; Ishihara, Tadashi; Kondo, Yutaka; Kawasaki, Takaaki; Takeuchi, Y.; Nakamura, Yuki; Ishikawa, Kouhei; Watanabe, Yusuke; Saito, Wataru; Matsuda, Shigeru; Nakazawa, Takeshi; Sasaki, Shin‐ichi; Tazaki, Hiroshi

doi:10.1002/ams2.569

Cited by 2 publications

(1 citation statement)

References 16 publications

(30 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…steroids from day 20th of administration until 27th which was successful. The current report highlights the need for future trials to evaluate the best treatment timing and doses for ARDS induced by COVID-19, as well as selecting the optimal population for different severity COVID-19-induced ARDS [ 83 ]. Due to the affordability and accessibility of corticosteroids in healthcare systems trembling under the strain of the worldwide outbreak of this coronavirus, this area of research should be a universal priority [ 74 ].…”

Section: Emerging Therapies For Covid-19-induced Ardsmentioning

confidence: 99%

Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic management

Aslan

Zolbanin

et al. 2021

Pneumonia

View full text Add to dashboard Cite

COVID-19 pandemic is a serious concern in the new era. Acute respiratory distress syndrome (ARDS), and lung failure are the main lung diseases in COVID-19 patients. Even though COVID-19 vaccinations are available now, there is still an urgent need to find potential treatments to ease the effects of COVID-19 on already sick patients. Multiple experimental drugs have been approved by the FDA with unknown efficacy and possible adverse effects. Probably the increasing number of studies worldwide examining the potential COVID-19 related therapies will help to identification of effective ARDS treatment. In this review article, we first provide a summary on immunopathology of ARDS next we will give an overview of management of patients with COVID-19 requiring intensive care unit (ICU), while focusing on the current treatment strategies being evaluated in the clinical trials in COVID-19-induced ARDS patients.

show abstract

Section: Emerging Therapies For Covid-19-induced Ardsmentioning

confidence: 99%

Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic management

Aslan

Zolbanin

et al. 2021

Pneumonia

View full text Add to dashboard Cite

show abstract

Fudan Zenshin, Kyumeikyukyu ; <sub>~</sub>Now JIN again<sub>~</sub>

Tanaka

2022

Juntendo Medical Journal

Self Cite

View full text Add to dashboard Cite

Summary I graduated from Osaka University in 1982 and joined the Department of Traumatology, Osaka University Medical School. Patients with severe injuries and illnesses were brought in every day. Staff brushed up their skills on site, taught each other, and engaged in friendly competition for research. We had many frustrating moments when we could not save lives. Since then, the needs of emergency medicine have changed, and the scope of practice of emergency physicians has expanded to include pre-hospital emergency care, primary health care, intensive care, and disaster medicine. I was transferred to Juntendo University Urayasu Hospital in September 2007. Soon after my assignment, Urayasu Hospital was in the spotlight due to the emergency hospitalization of the All-Japan soccer coach and the Chinese frozen dumpling incident. It is said that emergency medicine is a mirror of society. I myself have experienced many disasters and incidents. It has been 15 years since I was assigned to this hospital, and I have 62 colleagues at Urayasu Hospital. They have all acquired various medical specialties, and some are emergency medicine specialists. In 2019, we hosted the 47th Annual Meeting of the Japanese Association for Acute Medicine. The theme of the conference is “Fudan Zenshin, Kyumeikyukyu (constant advancement, emergency medical services)”. Emergency medical care is the starting point of “medicine” and is the ultimate source of life preservation for all citizens. We emergency physicians will continue to provide lifesaving medical care to patients without giving up until the very end, to keep the light of life from going out.

show abstract

Late i.v. steroid treatment for severe COVID‐19‐induced acute respiratory distress syndrome: a case report

Abstract: We report a case of COVID‐19‐induced extracorporeal membrane oxygenation treated by late i.v. steroid administration. Our case suggests the value of prospective clinical trials for the evaluation of steroid use in severe COVID‐19‐induced extracorporeal membrane oxygenation.

Cited by 2 publications

References 16 publications

Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic management

Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic management

Fudan Zenshin, Kyumeikyukyu ; <sub>~</sub>Now JIN again<sub>~</sub>

Contact Info

Product

Resources

About